AIM
Aigen Investment Management’s Thermo Fisher Scientific TMO Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $4.43M | Buy |
10,915
+6,478
| +146% | +$2.63M | 0.61% | 21 |
|
|
2025
Q1 | $2.21M | Buy |
4,437
+1,206
| +37% | +$600K | 0.35% | 64 |
|
|
2024
Q4 | $1.68M | Buy |
+3,231
| New | +$1.68M | 0.3% | 87 |
|
|
2024
Q3 | – | Sell |
-1,162
| Closed | -$643K | – | 1013 |
|
|
2024
Q2 | $643K | Buy |
+1,162
| New | +$643K | 0.13% | 237 |
|
|
2024
Q1 | – | Sell |
-4,442
| Closed | -$2.36M | – | 1014 |
|
|
2023
Q4 | $2.36M | Buy |
4,442
+2,284
| +106% | +$1.21M | 0.42% | 42 |
|
|
2023
Q3 | $1.09M | Buy |
+2,158
| New | +$1.09M | 0.21% | 142 |
|
|
2023
Q2 | – | Sell |
-644
| Closed | -$371K | – | 963 |
|
|
2023
Q1 | $371K | Buy |
+644
| New | +$371K | 0.05% | 374 |
|
|
2022
Q1 | – | Sell |
-3,376
| Closed | -$2.15M | – | 1071 |
|
|
2021
Q4 | $2.15M | Buy |
3,376
+1,912
| +131% | +$1.22M | 0.13% | 206 |
|
|
2021
Q3 | $836K | Sell |
1,464
-26,449
| -95% | -$15.1M | 0.16% | 165 |
|
|
2021
Q2 | $14.1M | Buy |
27,913
+16,507
| +145% | +$8.33M | 2.46% | 3 |
|
|
2021
Q1 | $5.21M | Buy |
+11,406
| New | +$5.21M | 0.69% | 35 |
|
|
2020
Q4 | – | Sell |
-8,669
| Closed | -$3.83M | – | 1054 |
|
|
2020
Q3 | $3.83M | Buy |
8,669
+7,762
| +856% | +$3.43M | 0.49% | 29 |
|
|
2020
Q2 | $329K | Sell |
907
-37,704
| -98% | -$13.7M | 0.04% | 595 |
|
|
2020
Q1 | $11M | Buy |
38,611
+36,341
| +1,601% | +$10.3M | 1.45% | 1 |
|
|
2019
Q4 | $737K | Buy |
+2,270
| New | +$737K | 0.12% | 243 |
|